Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN138,94139,08-0,71
Msft1,65
Nokia10,51510,585-6,55
IBM2,47
Mercedes-Benz Group AG50,3850,320,28
PFE-0,19
08.05.2026 1:38:51
Indexy online
AD Index online
select
AD Index online
 

  • 07.05.2026
West Pharm Svc (WST, NY Consolidated)
Závěr k 7.5.2026 Změna (%) Změna (USD) Objem obchodů (USD)
322,01 3,03 9,46 312 672 610
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiWest Pharmaceutical Services Inc
TickerWST
Kmenové akcie:Ordinary Shares
RICWST
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.03.2026
Počet zaměstnanců k 31.12.2025 10 800
Akcie v oběhu k 20.04.2026 70 647 595
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice530 Herman O. West Drive
MěstoEXTON
PSČ19341
ZeměUnited States
Kontatní osobaJohn Sweeny
Funkce kontaktní osobyVice President - Investor Relations
Telefon16 105 942 900
Fax18003459800
Kontatní telefon14 847 900 373

Business Summary: West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Financial Summary: BRIEF: For the three months ended 31 March 2026, West Pharmaceutical Services Inc revenues increased 21% to $844.9M. Net income increased 55% to $138.8M. Revenues reflect Proprietary Products segment increase of 23% to $694.3M, Contract-Manufactured Products segment increase of 12% to $150.6M, Europe Middle East and Africa segment increase of 29% to $397.1M, Americas segment increase of 11% to $380.2M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSMedical Laboratories
NAICSSurgical Appliance and Supplies Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSFabric Coating Mills
NAICSAll Other Miscellaneous Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Medical Laboratories
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Medical Laboratories
SICSurgical And Medical Instruments
SICMedical Laboratories
SICSurgical Appliances And Supplies
SICDrugs/proprietaries/sundries
SICMedical And Hospital Equipment
SICFinishing Plants, Manmade
SICManufacturing Industries, Nec
SICCommercial Physical Research



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Non-Independent Chairman of the Board, President, Chief Executive OfficerEric Green5624.05.202224.04.2015
Chief Financial Officer, Senior Vice PresidentRobert Mcmahon5604.08.202504.08.2025
Chief Human Resources Officer, Senior Vice PresidentAnnette Favorite6105.10.201505.10.2015
Senior Vice President, General Counsel, Corporate SecretaryNorman Finch61
Senior Vice President, Chief Proprietary Segment OfficerShane Campbell4505.05.202505.05.2025
Senior Vice President - Strategy and Corporate DevelopmentJudy Poussot48
Chief Accounting Officer, Vice President - FinanceChad Winters4705.05.2020